Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
EY-Parthenon teams can help your consumer products and retail business identify and implement strategies
3-10 Exenatide and lixisenatide are not included in this article
Heres how that total breaks down: Ozempic: $914.8 million Wegovy: $691.2 million Combined: $1.606 billion Total Medi-Cal Drug Spend in 2024: $16.1 billion This level of spending helped drive the states decision to remove GLP-1s from its covered Medi-Cal formulary in 202526
10.1016/S0140-6736(85)91481-3
Housset C, Chrtien Y, Debray D et al
/assets/images/provider/photos/2798511.png)
P., Slebodnik, M
US$ 21.89
US$ 27.07
US$ 20.76
US$ 29.46
US$ 24.45
US$ 28.62
US$ 26.39
US$ 25.78
